Description
GSK3685032 is an inhibitor of DNA methyltransferase 1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
GSK3685032 is an inhibitor of DNA methyltransferase 1.
| Cas No. | 2170137-61-6 |
|---|---|
| Purity | ≥98% |
| Formula | C22H24N6OS |
| Formula Wt. | 420.54 |
| IUPAC Name | 2-[6-(4-aminopiperidin-1-yl)-3,5-dicyano-4-ethylpyridin-2-yl]sulfanyl-2-phenylacetamide |
| Synonym | GSK-3685032 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Wiseman A, Tiedemann R, Fan H, et al. Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1. Commun Biol. 2022 Jun 2;5(1):528. PMID: 35654826
Pappalardi M, Keenan K, Cockerill M, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer. 2021 Oct;2(10):1002-1017. PMID: 34790902
L-type Ca2+ channel blocker.
Ellagic acid derivative produced by gut microfl...
Mycotoxin produced by Aspergillus and Penicillu...
EGFR (WT, T790M) inhibitor.
IGF-1R and InsR inhibitor.
Non-depolarizing NMJ blocker; AChR antagonist.<...
α2-adrenergic agonist.
Synthetic steroid hormone; ER agonist.
Calcium channel blocker.
Mesalazine derivative, sulfa drug; sepiapterin ...
ATP-sensitive K+ channel blocker, potential RyR...
Diphenylmethane, inhibits secretion of cortisol...
Toxin produced by Aspergillus.
PKMYT1 inhibitor
Dihydropyridine; L-type and T-type Ca2+ channel...
BHA derivative.
Heterocyclic light-emitting compound, natural l...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Non-depolarizing NMJ blocker; nAChR antagonist....
Bone deterioration inhibitor, potential CaR ago...